USE IN PREGNANCY When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, AVAPRO should be discontinued as soon as possible. (See WARNINGS: Fetal/Neonatal Morbidity and Mortality.) | ||||
advertisement

Email this article
Printer friendly
Bookmark this page












